Get the Stockscreener App
1.75
8.66%
0.1395
After Hours:
1.68
-0.07
-4.00%
Estrella Immunopharma Inc stock is traded at $1.75, with a volume of 421.30K.
It is up +8.66% in the last 24 hours and up +49.57% over the past month.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
See More
Previous Close:
$1.6105
Open:
$1.52
24h Volume:
421.30K
Relative Volume:
5.00
Market Cap:
$64.86M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-5.8333
EPS:
-0.3
Net Cash Flow:
$-18.01M
1W Performance:
+35.66%
1M Performance:
+49.57%
6M Performance:
+120.53%
1Y Performance:
+108.33%
1-Day Range:
$1.52
$1.90
1-Week Range:
$1.3187
$1.90
52-Week Range:
$0.63
$1.90
Estrella Immunopharma Inc Stock (ESLA) Company Profile
Name
Estrella Immunopharma Inc
Sector
Industry
Phone
(510) 318-9098
Address
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
1.75 | 59.69M | 0 | -8.82M | -18.01M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Estrella Immunopharma Inc Stock (ESLA) Latest News
Chart based exit strategy for Estrella Immunopharma Inc.Layoff News & Accurate Buy Signal Notifications - newser.com
Why Estrella Immunopharma Inc. stock attracts high net worth investorsMarket Sentiment Report & Community Verified Trade Alerts - newser.com
What analysts say about Estrella Immunopharma Inc stockHealthcare Stock Analysis & Budget Friendly Stock Tips - earlytimes.in
Applying chart zones and confluence areas to Estrella Immunopharma Inc.2025 Growth vs Value & Weekly Market Pulse Updates - newser.com
Leading vs lagging indicators on Estrella Immunopharma Inc. performance2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com
Using AI based signals to follow Estrella Immunopharma Inc.Analyst Downgrade & Expert Curated Trade Ideas - newser.com
Published on: 2025-10-15 10:58:20 - newser.com
Can Estrella Immunopharma Inc. recover in the next quarterStop Loss & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-10-15 10:08:30 - newser.com
Published on: 2025-10-15 03:01:25 - newser.com
What indicators show strength in Estrella Immunopharma Inc.July 2025 Volume & Reliable Price Breakout Alerts - newser.com
Is Estrella Immunopharma Inc. stock attractive for income investorsWeekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
How sentiment analysis helps forecast Estrella Immunopharma Inc.Weekly Investment Report & Stock Portfolio Risk Management - newser.com
Published on: 2025-10-13 08:06:06 - newser.com
What candlestick patterns are forming on Estrella Immunopharma Inc.July 2025 Final Week & AI Driven Stock Movement Reports - newser.com
How to manage a losing position in Estrella Immunopharma Inc.July 2025 Reactions & Accurate Buy Signal Alerts - newser.com
Estrella Immunopharma regains Nasdaq compliance after capital raise By Investing.com - Investing.com Nigeria
How to use Fibonacci retracement on Estrella Immunopharma Inc.Market Risk Report & Fast Moving Stock Watchlists - newser.com
Estrella Immunopharma regains Nasdaq compliance after capital raise - Investing.com
Estrella Immunopharma Inc. stock chart pattern explained2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
Estrella Immunopharma regains compliance with Nasdaq listing requirements - MarketScreener
Estrella Immunopharma Regains Compliance with Nasdaq Listing Requirements - Business Wire
Real time alert setup for Estrella Immunopharma Inc. performanceJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Published on: 2025-10-05 04:47:47 - newser.com
Will Estrella Immunopharma Inc. stock recover after recent dropIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Order flow analysis tools used on Estrella Immunopharma Inc.July 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Published on: 2025-10-05 02:31:05 - newser.com
Is Estrella Immunopharma Inc a good long term investmentDividend Aristocrats List & Free Explosive Wealth Accumulation - earlytimes.in
Published on: 2025-10-03 04:11:09 - newser.com
Morning Market Movers: ASBP, FICO, ESLA See Big Swings - RTTNews
Estrella Immunopharma Inc Stock (ESLA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):